OLIN Corp financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data OLIN Corp files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	5,551	6,268	6,946	6,110	5,758	8,911	9,376	6,833	6,540	6,781
Cost of revenue	4,945	5,555	5,822	5,439	5,375	6,616	7,194	5,668	5,803	6,279
Gross profit	606	714	1,124	671	383	2,294	2,182	1,166	738	502
Selling, general and administrative	347	370	431	417	422	417	394	407	409	463
Operating income	108	297	677	178	-747	1,851	1,779	712	297	5.3
Interest expense	192	217	243	243	293	348	144	181	185	188
Interest income	3.4	1.8	1.6	1	0.5	0.2	2.2	4.3	3.7	4.4
Pre-tax income	-34.2	117	437	-36.9	-1,020	1,539	1,676	559	142	-161
Income tax	-30.3	-432	109	-25.6	-50.1	242	349	107	36.7	-60
Income from continuing operations	-3.9
Net income to minority interests						0	0	-8.2	-3.6	-0.6
Net income	-3.9	550	328	-11.3	-970	1,297	1,327	452	105	-101
EBITDA	641	856	1,278	775	-178	2,433	2,378	1,246	815	527
EPS, basic	-0.02	3.31	1.97	-0.07	-6.14	8.15	9.16	3.66	0.92	-0.88
EPS, diluted	-0.02	3.26	1.95	-0.07	-6.14	7.96	8.94	3.57	0.91	-0.88
Shares, basic (weighted)	165	166	167	162	158	159	145	126	118	115
Shares, diluted (weighted)	165	169	168	162	158	163	149	129	120	115
Dividend per share	0.80	0.80	0.80	0.80	0.80

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	185	218	179	221	190	181	194	170	176	168
Short-term investments	0	0	0	0	0	0	0	0	0	0
Receivables	675	733	776	760
Inventory	630	683	711	696	675	868	942	859	824	785
Other current assets	30.8	48.1	35	23.1	66.7	92.7	52.7	54.1	61.4	108
Total current assets	1,546	1,699	1,707	1,714	1,717	2,248	2,156	1,973	2,080	1,971
Property, plant and equipment	3,705	3,576	3,482	3,324	3,171	2,914	2,674	2,520	2,328	2,197
Lease right-of-use assets			0	378	361	372	356	345	302	299
Goodwill	2,118	2,120	2,120	2,120	1,420	1,421	1,421	1,424	1,424	1,428
Intangible assets	630	579	512	448	399	332	274	246	207	174
Other non-current assets	644	1,208	1,150	1,169	1,191	1,132	1,103	1,119	1,185	1,210
Total assets	8,763	9,218	8,997	9,188	8,271	8,518	8,044	7,713	7,579	7,326
Accounts payable	571	670	637	652	729	848	838	775	862	806
Accrued liabilities	264	274	333	329	358	458	509	450	436	630
Deferred revenue								34.5	23.2	38.6
Short-term debt	80.5	0.7	126	2.1	26.3	201	9.7	78.8	129	110
Total current liabilities	923	954	1,118	1,082	1,199	1,682	1,561	1,528	1,632	1,630
Long-term debt	3,537	3,611	3,104	3,339	3,838	2,578	2,571	2,591	2,713	2,718
Lease liabilities			0	303	292	302	293	283	243	253
Other non-current liabilities	359	752	749	794	316	362	334	340	307	337
Total liabilities	6,490	6,465	6,165	6,770	6,820	5,866	5,501	5,445	5,524	5,455
Total debt	3,618	3,612	3,230	3,341	3,864	2,779	2,581	2,591	2,713	2,718
Paid-in capital	2,244	2,281	2,247	2,122	2,138	1,970	683	24.8	0	0
Retained earnings	374	790	1,071	941	-155	1,014	2,225	2,584	2,358	2,140
Other comprehensive income	-510	-485	-651	-803	-690	-488	-496	-496	-450	-415
Shareholders' equity	2,273	2,754	2,832	2,418	1,451	2,652	2,544	2,232	2,023	1,839
Minority interests							0	35.9	32.3	31.7
Total equity	2,273	2,754	2,832	2,418	1,451	2,652	2,544	2,268	2,055	1,871
Total liabilities and equity	8,763	9,218	8,997	9,188	8,271	8,518	8,044	7,713	7,579	7,326
Shares outstanding	165	167	165	158	158	157	132	120	116	114

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-3.9	550	328	-11.3	-970	1,297	1,327	452	105	-101
Depreciation and amortization	534	559	601	597	568	583	599	533	518	522
Stock-based compensation	7.5	9.1	12	10.7	13.6	8.3	14.1	18.6	17.1	20.7
Deferred income tax	-35.3	-455	34.6	-45.7	-20.2	-53.4	-28.7	-56.3	-39.8	-91.7
Change in receivables	38.5	-49.9	-46.3	12.3	-0.3	-360	161	65.4	-119	124
Change in inventory	23.9	-37.8	-35.5	13	28.6	-206	-86.3	94.4	25.9	80
Change in payables	-13.1	100	-14.5	-11	149	240	-22.3	-134	72.8	128
Cash from operations	603	649	908	617	433	1,741	1,922	974	503	474
Capital expenditures	-278	-294	-385	-386	-299	-201	-237	-236	-195	-226
Acquisitions	-69.5	0	0			0	0	63.9	0	55.8
Cash from investing	-474	-499	-382	-366	-836	-197	-260	-341	-284	-320
Debt issued	230	2,036	570	825	1,828	540	415	708	1,082	2,755
Debt repaid	-435	-2,038	-946	-744	-1,307	-1,643	-616	-622	-912	-2,766
Stock issued	0.5	29.8	3.4	1.7	1.9	72.4	25.7	25.4	23.9	2.3
Share buybacks	0	0	-50	-146	0	-252	-1,351	-711	-300	-50.5
Dividends paid	-132	-133	-134	-129	-126	-128	-116	-101	-94.2	-91.6
Cash from financing	-338	-117	-565	-209	371	-1,552	-1,647	-657	-213	-163
Exchange rate effect	0.3	0.4	-0.3	-0.3	0.5	-0.8	-2	-0.3	-1.6	0.4
Net change in cash	-208	33.9	-39.6	42.1	-31.2	-9.2	13.5	-23.7	5.3	-8
Free cash flow	325	355	523	232	134	1,540	1,685	738	308	248
Interest paid	201	201	209	198	286	345	142	177	181	178
Income taxes paid	-2.6	18	52.9	36.3	-9.6	170	357	112	106	167

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $16.40 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	6.9%	Gross profit / revenue.
Operating margin	-1.6%	Operating income / revenue.
EBITDA margin	5.9%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-4.0%	Pre-tax income / revenue.
Net margin	-2.9%	Net income / revenue.
Operating cash flow margin	4.6%	Cash from operations / revenue.
Return on equity (ROE)	-11.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-2.7%	Net income / average total assets.
Return on invested capital (ROIC)	-1.8%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	7.7%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.4%	Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue	7.4%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	3.7%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-10.2%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	3.3%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-32.0%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-38.7%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	5.5%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-98.2%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-85.6%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y	-35.3%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-39.5%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y	-196.3%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	-196.7%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	-5.8%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-37.3%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	1.8%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-19.5%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-47.2%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	13.1%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-9.1%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-10.2%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	4.9%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-3.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-3.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-2.4%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-4.1%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-8.3%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-6.2%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.42x	Current assets / current liabilities.
Quick ratio	0.11x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.11x	(Cash + short-term investments) / current liabilities.
Debt / equity	1.77x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	40.7%	Total debt / total assets.
Liabilities / assets	77.0%	Total liabilities / total assets.
Net debt	$2.85B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	7.25x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	-0.58x	Operating income / interest expense.
Working capital	$644.8M	Current assets - current liabilities.
Goodwill and intangibles / assets	21.3%	(Goodwill + intangible assets) / total assets.
Tangible book value	$128.1M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.90x	Revenue / average total assets.
Fixed asset turnover	3.21x	Revenue / average property, plant and equipment.
Inventory turnover	7.37x	Cost of revenue / average inventory.
Days inventory	50 days	365 x average inventory / cost of revenue.
Days payables	53 days	365 x average accounts payable / cost of revenue.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$1.73	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$58.85	Revenue / diluted weighted shares.
Operating cash flow per share	$2.70	Cash from operations / diluted weighted shares.
Book value per share	$15.01	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$1.12	Tangible book value / shares outstanding.
Cash per share	$1.56	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$1.87B	Share price x shares outstanding.
Enterprise value	$4.72B	Market cap + total debt - cash - short-term investments.
P/S	0.28x	Market cap / revenue.
P/B	1.09x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	14.6x	Market cap / tangible book value, when positive.
P/OCF	6.09x	Market cap / cash from operations, when positive.
EV/Sales	0.70x	Enterprise value / revenue.
EV/EBITDA	12.0x	Enterprise value / EBITDA, when both are positive.
Earnings yield	-10.6%	Net income / market cap (the inverse of P/E).
Dividend yield	4.9%	Dividends paid over the period / market cap.
Shareholder yield	6.0%	(Dividends paid + share buybacks) / market cap.

What was OLIN Corp's revenue in fiscal 2025?

OLIN Corp reported revenue of $6.78B for fiscal 2025, 3.7% higher than the year before.

Was OLIN Corp profitable in fiscal 2025?

No. It reported a net loss of $101.1M.

How much free cash flow did OLIN Corp generate in fiscal 2025?

Cash from operations of $474.2M minus capital expenditures of $226.3M left free cash flow of $247.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to OLIN Corp